Authors: KRUGER W STOCKSCHLADER M SOBOTTKA I BETKER R DEWIT M KROGER N GRIMM J ARLAND M FIEDLER W ERTTMANN R ZANDER AR

Citation: W. Kruger et al., ANTIMYCOTIC THERAPY WITH LIPOSOMAL AMPHOTERICIN-B FOR PATIENTS UNDERGOING BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Leukemia & lymphoma, 24(5-6), 1997, pp. 491-499

Authors: HORSTMANN M KROSCHKE G STOCKSCHLADER M BETKER R KRUGER W ERTTMANN R KABISCH H ZANDER A

Citation: M. Horstmann et al., EARLY TOXICITY OF INTENSIFIED CONDITIONING WITH ETOPOSIDE COMBINED WITH TOTAL-BODY IRRADIATION CYCLOPHOSPHAMIDE OR BUSULFAN CYCLOPHOSPHAMIDE IN CHILDREN UNDERGOING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION, Pediatric hematology and oncology, 13(1), 1996, pp. 45-53

Authors: STOCKSCHLADER M KRUGER W BETKER R LOLIGER C DEWIT M HORSTMANN M KROGER N ERTTMANN R ZANDER R

Citation: M. Stockschlader et al., ATG AS PART OF THE PRETRANSPLANT CONDITIONING REGIMEN REDUCES TRANSPLANT-RELATED MORTALITY IN CML PATIENTS UNDERGOING ALLOGENEIC BMT, Experimental hematology, 24(9), 1996, pp. 679-679

Authors: KRUGER W SOBOTTKA I STOCKSCHLADER M MROSS K HOFFKNECHT M RUSSMANN B HORSTMANN M BETKER R ZANDER A

Citation: W. Kruger et al., FATAL OUTCOME OF DISSEMINATED CANDIDOSIS AFTER ALLOGENEIC BONE-MARROWTRANSPLANTATION UNDER TREATMENT WITH LIPOSOMAL AND CONVENTIONAL AMPHOTERICIN-B - A REPORT OF 4 CASES WITH DETERMINATION OF THE MIC VALUES, Scandinavian journal of infectious diseases, 28(3), 1996, pp. 313-316

Authors: HORSTMANN M STOCKSCHLADER M KRUGER W HOFFKNECHT M BETKER R KABISCH H ZANDER A

Citation: M. Horstmann et al., CYCLOPHOSPHAMIDE ANTITHYMOCYTE GLOBULIN CONDITIONING OF PATIENTS WITHSEVERE APLASTIC-ANEMIA FOR MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - PRELIMINARY-RESULTS/, Annals of hematology, 71(2), 1995, pp. 77-81

Authors: STOCKSCHLADER M KRUGER W DIECK AT BETKER R ERTTMANN R HOFFKNECHT M ZANDER A

Citation: M. Stockschlader et al., USE OF CRYOPRESERVED BONE-MARROW CELLS IN UNRELATED ALLOGENEIC TRANSPLANTATION, Blood, 86(10), 1995, pp. 1556-1556